Clinical Trial - Trial ChiCTR2200056545

Name: Clinical Trial ChiCTR2200056545
Creator: Liaoning Cancer Hospital & Institute/Cancer Hospital of Daliian University of Technology
Keywords: gastric cancer, Phase 2, clinical trial, China

Access comprehensive clinical trial information for ChiCTR2200056545 through Pure Global AI's free database. This Phase 2 trial is sponsored by Liaoning Cancer Hospital & Institute/Cancer Hospital of Daliian University of Technology and is currently Not yet recruiting. The study focuses on gastric cancer.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database

840K+ Trials

ChiCTR2200056545

Phase 2

Not yet recruiting

Trial Details

Chinese Clinical Trial Registry • ChiCTR2200056545

View on Chinese Clinical Trial Registry

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Untitled Trial

A randomized controlled clinical study of hyperthermic intraperitoneal chemotherapy (HIPEC) combined with intraperitoneal infusion chemotherapy for gastric cancer with peritoneal metastasis

Study Focus

Disease/Condition

gastric cancer

Sponsor & Location

Primary Sponsor

Liaoning Cancer Hospital & Institute/Cancer Hospital of Daliian University of Technology

Funder

Location

China

Timeline & Enrollment

Phase

Phase 2

Start Date

N/A

End Date

Jul 31, 2024

ICD-10 Classifications

Gastric ulcer

Malignant neoplasm of stomach

Malignant neoplasm: Body of stomach

Carcinoma in situ: Stomach

Malignant neoplasm: Stomach, unspecified

Data Source

Registry

Chinese Clinical Trial Registry

Trial ID

ChiCTR2200056545

Type

Non-Device Trial